Navigation Links
Aware, Inc. Reports Third Quarter 2011 Financial Results
Date:10/25/2011

BEDFORD, Mass., Oct. 25, 2011 /PRNewswire/ -- Aware, Inc. (NASDAQ: AWRE), a leading supplier of broadband technology and biometrics software, today reported financial results for its third quarter ended September 30, 2011.  

Revenue for the third quarter of 2011 was $6.4 million, an increase of 4% compared to $6.2 million in the same quarter last year. Net income for the third quarter of 2011 was $1.3 million, or $0.06 per diluted share. These results compared to net income of $76,000, or $0.00 per diluted share, for the same period a year ago.

For the nine months ended September 30, 2011, revenue increased 12% to $18.7 million, compared to $16.7 million in the same period a year ago. Net income for the nine months ended September 30, 2011 was $1.6 million, or $0.08 per diluted share. These results compared to a net loss of $50,000, or $0.00 per diluted share, for the same period a year ago.

Additional information regarding third quarter financial results is presented below:

Product revenue declined 2% from $5.0 million in the third quarter of 2010 to $4.9 million this quarter. The slight decrease in product revenue reflects a $1.3 million decrease in test and diagnostics hardware and software revenue that was mostly offset by a $1.2 million increase in biometrics software revenue.

Services revenue grew 99% from $488,000 in the third quarter of 2010 to $971,000 this quarter. The rise in services revenue was primarily due to increased revenue from biometrics engineering projects.  

Royalties declined 14% from $637,000 in the third quarter of 2010 to $549,000 this quarter. The decrease in royalties was due to lower royalties reported to us by one of our legacy DSL chip licensees.

Spending declined 17% from $6.2 million in the third quarter of 2010 to $5.2 million this quarter. The $1.0 million spending decrease was primarily t
'/>"/>

SOURCE Aware, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology news :

1. Aware, Inc. Reports Second Quarter 2011 Financial Results
2. Aware, Inc. Reports Second Quarter 2011 Financial Results
3. Aware, Inc. Announces Resignation of Chief Executive Officer
4. Aware, Inc. Reports First Quarter 2011 Financial Results
5. Aware, Inc. Announces Resignation of Chief Executive Officer
6. Aware, Inc. Announces Q4 and FY2010 Earnings Conference Call
7. Aware, Inc. Announces Q4 and FY2010 Earnings Conference Call
8. Aware, Inc. Reports Third Quarter 2010 Financial Results
9. Aware, Inc. Announces Q310 Earnings Conference Call
10. Aware, Inc. Reports Second Quarter 2010 Financial Results
11. Aware, Inc. Joins HIMSS10 Interoperability Showcase to Demonstrate Standards-Based Medical Image Sharing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/11/2015)... BOSTON , March 11, 2015   ... of its platform to scientifically measure and harness ... characteristics to real-time biometrics and objective measurements of ... of music at scale in large populations. It ... scientists, technologists and clinicians perform rigorous studies and ...
(Date:3/5/2015)... , March 5, 2015 In ... percent of companies already using these solutions and 42 percent ... Of the latter, approximately 25 percent of the companies will ... While the majority of companies in the region are ... that the hybrid model will command significant attention in the ...
(Date:3/2/2015)... Lithuania , March 2, 2015   Neurotechnology ... technologies, today introduced the SentiGaze Software Development Kit ... to create applications that use off-the-shelf webcams to track ... user gazes at a monitor. Heatmaps can be used ... the effectiveness of online advertising. The SDK can also ...
Breaking Biology News(10 mins):Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3
... at National Jewish Health have discovered specific molecular and ... their experiments, they showed that low levels of Vitamin ... failed to inhibit the inflammatory cascade, while levels considered ... in the March 1, 2011, issue of The ...
... study from the Swedish medical university Karolinska Institutet shows that ... an increased risk of developing autism with intellectual disability. The ... 2007, and brings the question of the heredity of autism ... in which we can see strong links between a certain ...
... After we sense a threat, our brain center responsible ... biochemical reactions leading to the release of cortisol from the ... team in the Molecular Cell Biology Department have now revealed ... regulating the production of a main biochemical signal from the ...
Cached Biology News:Researchers discover how vitamin D inhibits inflammation 2Higher risk of autism among certain immigrant groups 2A unique on-off switch for hormone production 2
(Date:3/27/2015)... -- Neogen Corporation (NASDAQ: NEOG ) announced today that ... in accordance with Securities and Exchange Commission rule 10b5-1. ... Corporation, is a minority owner of this entity that ... Herbert does not have control of this entity, but ... for a portion of the shares owned by that ...
(Date:3/27/2015)... , March 27, 2015 WuXi ... leading open-access R&D capability and technology platform company ... industries, announced today that an Investigational New Drug ... antibody for rheumatoid arthritis has been accepted for ... (CFDA).  In September 2012, MedImmune, ...
(Date:3/26/2015)... PRC Clinical, a Silicon-Valley based ... and executive appointments effective immediately. , Mike Catelani will ... member of the Board of Directors. Daniel Head is ... Dowden will assume the position of Senior Director of ... Officer (COO), has been appointed to the position of ...
(Date:3/26/2015)... CINCINNATI , March 26, 2015 /PRNewswire/ ... SHPG ) and Cincinnati Children,s Hospital Medical ... for rare diseases. The goal of the collaboration is ... rare diseases with high unmet medical need combining ... research expertise. As a nationally ranked hospital, Cincinnati ...
Breaking Biology Technology:Neogen CEO adopts 10b5-1 Trading Plan 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 3PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 2PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 3Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 2Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 3Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 4Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 5
... ... , ... (PRWEB) March 11, 2010 -- ClearTrial, the leading provider of Clinical Trial Operations (CTO) ... Deutsche Bank and Cowen & Company at CBI,s 2010 Accounting and Reporting Congress in ...
... , CHICAGO , March 11 ... a biopharmaceutical company engaged in the discovery, development and ... infection, oncology and respiratory diseases, announced today that the ... on the clinical program required to assess the approvability ...
... NBIX ) announced today that Kevin Gorman , President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Roth 22nd Annual OC Growth Conference in ... ... ... ...
Cached Biology Technology:ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress 2ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress 3Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications 2Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications 3Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications 4Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications 5Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications 6Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications 7Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications 8Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications 9Neurocrine Biosciences to Present at the Roth 22nd Annual OC Growth Conference 2
... The FastPrep System combines 2 products into ... , A molecular isolation kit , ... homogenizer machine and Qbiogene/BIO101 System Matrix and ... in individual micro tubes eliminating the use ...
... Blood bank refrigerators: ,Each upright model ... superior 4C temperature uniformity for refrigerated blood. ... 2000 Surveillance Module for complete blood storage ... are equipped with the HemaPro 101 alarm/monitor. ...
... AcTEV Protease is an enhanced form ... is highly site-specific, highly active, and significantly ... in long-term activity. AcTEV Protease specifically recognizes ... Gln and Gly), making it useful for ...
S-100A10 (H-80)...
Biology Products: